BioAdaptives Operating Income

The latest operating income for BDPT is $-910K as of June 2026. That compares with $-990K in the prior-year period — up 8.1% year over year. Investors often review this figure alongside BioAdaptives's historical trend and sector peers before judging valuation or financial health.

Over the past year, BDPT's operating income moved from $-990K to $-910K — a 8.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in BioAdaptives's operating scale or balance-sheet position.

A operating income figure of $-910K for BDPT is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BDPT's operating income ($-910K), review year-over-year change from $-990K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.